Bridge City Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
LCOV
LCP
Bridge City Capital's HAE Position: Q2 2021 in Review
Bridge City Capital sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 48,011 shares — an estimated $5.33M sold.
Bridge City Capital first reported a position in HAE in Q2 2017 and held it in 16 quarters. The position peaked at $5.76M in Q4 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.
- Bridge City Capital reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
- Bridge City Capital sold 48,011 Haemonetics shares in Q2 2021, an estimated $5.33M.
- Bridge City Capital first reported a position in Haemonetics in Q2 2017 and held it in 16 quarters.
- Bridge City Capital's Haemonetics position peaked at $5.76M in Q4 2020.
- 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.
Based on Bridge City Capital's 13F filing for Q2 2021, filed 11 Aug 2021.